- About this Journal ·
- Abstracting and Indexing ·
- Advance Access ·
- Aims and Scope ·
- Annual Issues ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
BioMed Research International
Volume 2013 (2013), Article ID 206061, 5 pages
Induction of Mast-Cell Accumulation by Promutoxin, an Arg-49 Phospholipase
1Clinical Experiment Center, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
2Allergy and Inflammation Research Institute, The Shantou University Medical College, Shantou, Guangdong 515041, China
3Research Division of Clinical Pharmacology, The First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China
Received 23 July 2012; Accepted 11 September 2012
Academic Editor: Luis A. Ponce Soto
Copyright © 2013 Ji-Fu Wei et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- J. Polgár, E. M. Magnenat, M. C. Peitsch, T. N. C. Wells, and K. J. Clemetson, “Asp-49 is not an absolute prerequisite for the enzymic activity of low- phospholipases A2: purification, characterization and computer modelling of an enzymically active Ser-49 phospholipase A2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper),” Biochemical Journal, vol. 319, no. 3, pp. 961–968, 1996.
- I. Krizaj, A. L. Bieber, A. Ritonja, and F. Gubensek, “The primary structure of ammodytin L, a myotoxic phospholipase A2 homologue from Vipera ammodytes venom,” European Journal of Biochemistry, vol. 202, no. 3, pp. 1165–1168, 1991.
- X. Zhou, T. C. Tan, S. Valiyaveettil et al., “Structural characterization of myotoxic ecarpholin S from Echis carinatus venom,” Biophysical Journal, vol. 95, no. 7, pp. 3366–3380, 2008.
- I. H. Tsai, Y. M. Wang, Y. H. Chen, T. S. Tsai, and M. C. Tu, “Venom phospholipases A2 of bamboo viper (Trimeresurus stejnegeri): molecular characterization, geographic variations and evidence of multiple ancestries,” Biochemical Journal, vol. 377, no. 1, pp. 215–223, 2004.
- J. F. Wei, X. L. Wei, Q. Y. Chen et al., “N49 phospholipase A2, a unique subgroup of snake venom group II phospholipase A2,” Biochimica et Biophysica Acta, vol. 1760, no. 3, pp. 462–471, 2006.
- T. Chijiwa, E. Tokunaga, R. Ikeda et al., “Discovery of novel [Arg49]phospholipase A2 isozymes from Protobothrops elegans venom and regional evolution of Crotalinae snake venom phospholipase A2 isozymes in the Southwestern islands of Japan and Taiwan,” Toxicon, vol. 48, no. 6, pp. 672–682, 2006.
- D. Mebs, U. Kuch, F. I. V. Coronas, C. V. F. Batista, A. Gumprecht, and L. D. Possani, “Biochemical and biological activities of the venom of the Chinese pitviper Zhaoermia mangshanensis, with the complete amino acid sequence and phylogenetic analysis of a novel Arg49 phospholipase A2 myotoxin,” Toxicon, vol. 47, no. 7, pp. 797–811, 2006.
- J. F. Wei, T. Li, X. L. Wei et al., “Purification, characterization and cytokine release function of a novel Arg-49 phospholipase A2 from the venom of Protobothrops mucrosquamatus,” Biochimie, vol. 88, no. 10, pp. 1331–1342, 2006.
- Q. M. Lu, Y. Jin, J. F. Wei et al., “Characterization and cloning of a novel phospholipase A2 from the venom of Trimeresurus jerdonii snake,” Toxicon, vol. 40, no. 9, pp. 1313–1319, 2002.
- Q. M. Lu, Y. Jin, J. F. Wei, W. Y. Wang, and Y. L. Xiong, “Biochemical and biological properties of Trimeresurus jerdonii venom and characterization of a platelet aggregation-inhibiting acidic phospholipase A2,” Journal of Natural Toxins, vol. 11, no. 1, pp. 25–33, 2002.
- R. M. Kini, “Structure-function relationships and mechanism of anticoagulant phospholipase A2 enzymes from snake venoms,” Toxicon, vol. 45, no. 8, pp. 1147–1161, 2005.
- I. H. Tsai, P. J. Lu, Y. M. Wang, C. L. Ho, and L. L. Liaw, “Molecular cloning and characterization of a neurotoxic phospholipase A2 from the venom of Taiwan habu (Trimeresurus mucrosquamatus),” Biochemical Journal, vol. 311, no. 3, pp. 895–900, 1995.
- A. M. Soares, R. Guerra-Sá, C. R. Borja-Oliveira et al., “Structural and functional characterization of BnSP-7, a Lys49 myotoxic phospholipase A2 homologue from Bothrops neuwiedi pauloensis venom,” Archives of Biochemistry and Biophysics, vol. 378, no. 2, pp. 201–209, 2000.
- A. M. Soares, S. H. Andrião-Escarso, Y. Angulo et al., “Structural and functional characterization of myotoxin I, a Lys49 phospholipase A2 homologue from Bothrops moojeni (Caissaca) snake venom,” Archives of Biochemistry and Biophysics, vol. 373, no. 1, pp. 7–15, 2000.
- M. M. Kanashiro, R. de Cássia M Escocard, J. H. Petretski et al., “Biochemical and biological properties of phospholipases A2 from Bothrops atrox snake venom,” Biochemical Pharmacology, vol. 64, no. 7, pp. 1179–1186, 2002.
- S. Lloret and J. J. Moreno, “Oedema formation and degranulation of mast cells by phospholipase A2 purified from porcine pancreas and snake venoms,” Toxicon, vol. 31, no. 8, pp. 949–956, 1993.
- E. C. T. Landucci, R. C. de Castro, M. Toyama et al., “Inflammatory oedema induced by the Lys-49 phospholipase A2 homologue piratoxin-i in the rat and rabbit: effect of polyanions and p-bromophenacyl bromide,” Biochemical Pharmacology, vol. 59, no. 10, pp. 1289–1294, 2000.
- C. F. P. Teixeira, E. C. T. Landucci, E. Antunes, M. Chacur, and Y. Cury, “Inflammatory effects of snake venom myotoxic phospholipases A2,” Toxicon, vol. 42, no. 8, pp. 947–962, 2003.
- J. P. Zuliani, J. M. Gutiérrez, L. L. Casais e Silva, S. C. Sampaio, B. Lomonte, and C. D. F. Pereira Teixeira, “Activation of cellular functions in macrophages by venom secretory Asp-49 and Lys-49 phospholipases A2,” Toxicon, vol. 46, no. 5, pp. 523–532, 2005.
- E. C. T. Landucci, R. C. Castro, M. F. Pereira et al., “Mast cell degranulation induced by two phospholipase A2 homologues: dissociation between enzymatic and biological activities,” European Journal of Pharmacology, vol. 343, no. 2-3, pp. 257–263, 1998.
- M. Metz, A. M. Piliponsky, C. C. Chan et al., “Mast cells can enhance resistance to snake and honeybee venoms,” Science, vol. 313, no. 5786, pp. 526–530, 2006.
- L. A. Schneider, S. M. Schlenner, T. B. Feyerabend, M. Wunderlin, and H. R. Rodewald, “Molecular mechanism of mast cell-mediated innate defense against endothelin and snake venom sarafotoxin,” Journal of Experimental Medicine, vol. 204, no. 11, pp. 2629–2639, 2007.
- J. F. Wei, X. L. Wei, Y. Z. Mo, and S. H. He, “Induction of mast cell accumulation, histamine release and skin edema by N49 phospholipase A2,” BMC Immunology, vol. 10, article 21, 2009.
- J. F. Wei, X. L. Wei, Y. Z. Mo, and S. H. He, “Induction of microvascular leakage and histamine release by promutoxin, an Arg49 phospholipase A2,” Toxicon, vol. 55, no. 4, pp. 888–896, 2010.
- J. F. Wei, X. L. Wei, Q. Y. Chen, and S. H. He, “Induction of inflammatory cell accumulation by TM-N49 and promutoxin, two novel phospholipase A2,” Toxicon, vol. 56, no. 4, pp. 580–588, 2010.
- K. Ishimaru, H. Kihara, and M. Ohno, “Purification and properties of phospholipase A2 from venom of Trimeresurus flavoviridis (Habu snake),” Journal of Biochemistry, vol. 88, no. 2, pp. 443–451, 1980.
- A. L. de Araújo and F. Radvanyi, “Determination of phospholipase A2 activity by a colorimetric assay using a pH indicator,” Toxicon, vol. 25, no. 11, pp. 1181–1188, 1987.
- C. A. Thomas, F. J. Yost Jr., R. Snyderman, et al., “Cellular serine proteinase induces chemotaxis by complement activation,” Nature, vol. 269, no. 5628, pp. 521–522, 1977.
- C. M. Fernandes, S. R. Zamuner, J. P. Zuliani, A. Rucavado, J. M. Gutiérrez, and C. F. Teixeira, “Inflammatory effects of BaP1 a metalloproteinase isolated from Bothrops asper snake venom: leukocyte recruitment and release of cytokines,” Toxicon, vol. 47, no. 5, pp. 549–559, 2006.
- S. R. Zamuner, J. P. Zuliani, C. M. Fernandes, J. M. Gutiérrez, and C. F. Teixeira, “Inflammation induced by Bothrops asper venom: release of proinflammatory cytokines and eicosanoids, and role of adhesion molecules in leukocyte infiltration,” Toxicon, vol. 46, no. 7, pp. 806–813, 2005.
- J. P. Zuliani, C. M. Fernandes, S. R. Zamuner, J. M. Gutiérrez, and C. F. Teixeira, “Inflammatory events induced by Lys-49 and Asp-49 phospholipases A2 isolated from Bothrops asper snake venom: role of catalytic activity,” Toxicon, vol. 45, no. 3, pp. 335–346, 2005.
- A. Takahara, A. Sugiyama, Y. Satoh, and K. Hashimoto, “Comparison of four rate-correction algorisms for the ventricular repolarization period in assessing net effects of IKr blockers in dogs,” Journal of Pharmacological Sciences, vol. 102, no. 4, pp. 396–404, 2006.
- A. Takahara, A. Sugiyama, and K. Hashimoto, “Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongation,” British Journal of Pharmacology, vol. 146, no. 4, pp. 561–567, 2005.
- I. A. Desouza and G. Ribeiro-DaSilva, “The pharmacological profile of mouse hind paw inflammation induced by staphylococcal enterotoxin type A,” Inflammation Research, vol. 46, no. 9, pp. 361–365, 1997.
- B. G. Southorn and R. M. Palmer, “Inhibitors of phospholipase A2 block the stimulation of protein synthesis by insulin in L6 myoblasts,” Biochemical Journal, vol. 270, no. 3, pp. 737–739, 1990.
- S. He, M. D. A. Gaça, and A. F. Walls, “A role for tryptase in the activation of human mast cells: modulation of histamine release by tryptase and inhibitors of tryptase,” Journal of Pharmacology and Experimental Therapeutics, vol. 286, no. 1, pp. 289–297, 1998.
- S. He, M. D. A. Gaça, A. R. McEuen, and A. F. Walls, “Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells,” Journal of Pharmacology and Experimental Therapeutics, vol. 291, no. 2, pp. 517–523, 1999.
- G. Lisignoli, S. Toneguzzi, A. Piacentini et al., “Recruitment and proliferation of T lymphocytes is supported by IFNγ- and TNFα-activated human osteoblasts: involvement of CD54 (ICAM-1) and CD106 (VCAM-1) adhesion molecules and CXCR3 chemokine receptor,” Journal of Cellular Physiology, vol. 198, no. 3, pp. 388–398, 2004.
- C. Duplàa, T. Couffinhal, L. Labat et al., “Monocyte/macrophage recruitment and expression of endothelial adhesion proteins in human atherosclerotic lesions,” Atherosclerosis, vol. 121, no. 2, pp. 253–266, 1996.
- M. Ebisawa, B. S. Bochner, S. N. Georas, and R. P. Schleimer, “Eosinophil transendothelial migration induced by cytokines. I. Role of endothelial and eosinophil adhesion molecules in IL-1β-induced transendothelial migration,” The Journal of Immunology, vol. 149, no. 12, pp. 4021–4028, 1992.
- E. Forbes, M. Hulet, R. Ahrens, et al., “ICAM-1-dependent pathways regulate colonic eosinophilic inflammation,” Journal of Leukocyte Biology, vol. 80, no. 2, pp. 330–341, 2006.